FDA Approves Celltrion’s EYDENZELT for Retinal Diseases
Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for...
Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for...
A lyophilizer is supposed to freeze and sublimate samples, not collect dust. If yours is idle more often than not,...
The U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly, extended-release injectable suspension for adults with...
The US Food and Drug Administration (FDA) has approved a new blood test aimed at assessing Alzheimer’s disease and other...
The European Investment Bank (EIB) and the European Commission (EC) are joining forces with BioNTech to push forward a mRNA...
Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected....
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare...
The FDA has granted approval to begin clinical trials of the AD-NP1 drug. It is a first-in-class drug for tissue...
The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within...
Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals have joined forces in a new collaboration that seeks to harness artificial...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.